683 Capital Management, LLC Mustang Bio, Inc. Transaction History

683 Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $1.39 Million - $2.37 Million	-460,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.57 - $4.08 $424,050 - $673,200	-165,000 Reduced 26.4%	460,000 $1.88 Million
Q2 2019 Aug 14, 2019	BUY	$2.66 - $6.28 $1.66 Million - $3.93 Million	625,000 New	625,000 $2.3 Million

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $23.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.